Allstate Corporation’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-63,815
Closed -$1.27M 802
2021
Q4
$1.27M Buy
63,815
+15,733
+33% +$296K 0.02% 487
2021
Q3
$873K Buy
48,082
+2,369
+5% +$54.3K 0.04% 324
2021
Q2
$1.23M Buy
45,713
+337
+0.7% +$9.43K 0.04% 257
2021
Q1
$1.36M Buy
45,376
+4,343
+11% +$148K 0.04% 253
2020
Q4
$1.18M Buy
41,033
+10,542
+35% +$285K 0.04% 250
2020
Q3
$744K Buy
+30,491
New +$658K 0.02% 307

Other funds holding CVET

Allstate Corporation's CVET Position: Q1 2022 in Review

Allstate Corporation sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2022, closing a stake of 63,815 shares — an estimated $1.27M sold.

Allstate Corporation first reported a position in CVET in Q3 2020 and held it in 6 quarters. The position peaked at $1.36M in Q1 2021. 257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

  • Allstate Corporation reported no remaining Covetrus, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 63,815 Covetrus, Inc. Common Stock shares in Q1 2022, an estimated $1.27M.
  • Allstate Corporation first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Allstate Corporation's Covetrus, Inc. Common Stock position peaked at $1.36M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.